SNGX stock is rising higher on an FDA update Soligenix (NASDAQ:SNGX) stock is rocketing higher on Monday after getting an orphan drug designation for the active ingredient in MarVax. This comes from the U.S. Food and Drug Administration’s (FDA) Office of Orphan Products Development. This…
#fda #marvax #marv #christopherschaber #soligenix #sngx #hawaiianelectric #piedmontlithium #buyinformatica #williamwhite
Continue reading...